News

FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots
There's new uncertainty about updated COVID-19 shots this fall after the Trump administration's handling of a shot from ...
Disability-rights arguments grow heated at Supreme Court, though sweeping ruling appears unlikely
At the insistence of Justice Neil Gorsuch, she withdrew the allegation that the other side had lied but held firm to the ...
Mexico and US reach deal on Rio Grande water sharing
“Mexico has committed to make an immediate transfer of water from international reservoirs and increase the U.S. share of the ...
FDA appears to be slow-walking vaccine approvals
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
Becker's Hospital Review3h
Feds ask for new clinical trial for Novavax COVID-19 shot
Federal regulators have requested that Novavax conduct an additional randomized clinical trial of its COVID-19 vaccine, a costly demand that could threaten the company’s ability to comply, The Wall ...
Novavax Stock Is Up Again. There Are Still Big Questions About the Fate of Its Covid Shot.
Novavax said Monday morning that the Food and Drug Administration was asking the company to run a new trial of its Covid-19 ...
BioPharma Dive9h
Novavax says vaccine application still ‘approvable,’ despite FDA delay
Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...
Infectious Disease Advisor12h
Novavax COVID-19 Vaccine Moves Closer to Full FDA Approval
Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.
Novavax: Grandiose Ambitions, Smart Strategy, But FDA Decision Adds To Challenges
Novavax shows financial improvement but faces vaccine challenges. Read why I rated NVAX stock as 'Hold' and what risks and ...